2017-06-15T15:06:02Z
2017-06-15T15:06:02Z
2016-03-10
2017-06-15T15:06:02Z
Inflammation and immune-mediated processes are pivotal to the pathogenic progression of age-related macular degeneration (AMD). Although plasma levels of C-reactive protein (CRP) have been shown to be associated with an increased risk for AMD, the pathophysiological importance of the prototypical acute-phase reactant in the etiology of the disease is unknown, and data regarding the exact role of CRP in ocular inflammation are limited. In this study, we provide mechanistic insight into how CRP contributes to the development of AMD. In particular, we show that monomeric CRP (mCRP) but not the pentameric form (pCRP) upregulates IL-8 and CCL2 levels in retinal pigment epithelial cells. Further, we show that complement factor H (FH) binds mCRP to dampen its proinflammatory activity. FH from AMD patients carrying the 'risk' His402 polymorphism displays impaired binding to mCRP, and therefore proinflammatory effects of mCRP remain unrestrained.
Article
Published version
English
Inflamació; Malalties de la retina; Degeneració (Patologia); Malalties de les persones grans; Inflammation; Retinal diseases; Degeneration (Pathology); Older people diseases
Nature Publishing Group
Reproducció del document publicat a: https://doi.org/10.1038/srep22889
Scientific Reports, 2016, vol. 6, num. 22889, p. 1-12
https://doi.org/10.1038/srep22889
cc-by (c) Molins Monteys, Blanca et al., 2016
http://creativecommons.org/licenses/by/3.0/es